Physician profile
Stacey L Webb
NPI 1275750986
$5,236.61
in general payments reported to CMS, 2019-2025
23 companies · $1,044 in 2025
The $1,044 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $115 · 2021: $481 · 2022: $1,119 · 2023: $1,250 · 2024: $793 · 2025: $1,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,998 · Entertainment: $88.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,998.39 |
| Entertainment | $88.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $825.17 | 2019-2025 | Clareon, Rocklatan, Rhopressa |
| Glaukos Corporation | $755.12 | 2023-2025 | Idosetr, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3, Radius Xr |
| Sun Pharmaceutical Industries INC. | $586.82 | 2019-2025 | Cequa |
| Abbvie INC. | $386.87 | 2022-2025 | Alphagan P, Lumigan, Durysta |
| Oyster Point Pharma, INC. | $363.70 | 2022-2024 | Tyrvaya |
| Notal Vision, INC. | $344.54 | 2022 | |
| Novartis Pharmaceuticals Corporation | $312.83 | 2019-2023 | |
| Biotissue Holdings INC. | $286.46 | 2025 | |
| Dompe US, INC. | $196.75 | 2021-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $189.01 | 2023-2024 | Vyzulta, Prolensa, Miebo |
| Allergan, INC. | $154.49 | 2019-2022 | |
| Rxsight INC | $149.23 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal) |
| Aerie Pharmaceuticals, INC. | $148.83 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $118.56 | 2021 | |
| Optos, INC. | $88.90 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $88.67 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $58.66 | 2024-2025 | Xdemvy |
| Dutch Ophthalmic, USA | $56.44 | 2025 | Eva, Combined Machine, Tissueblue |
| Carl Zeiss Meditec USA, INC. | $39.54 | 2021 | |
| Integra Lifesciences Corporation | $32.01 | 2019 | |
| Thea Pharma INC. | $24.35 | 2023 | |
| Sight Sciences, INC. | $18.53 | 2023 | Omni Surgical System |
| Eyevance Pharmaceuticals LLC | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.